Urinary glycosaminoglycan and proteoglycan excretion in normoalbuminuric patients with type 1 diabetes mellitus

Journal of Nephrology

Volumn 15, Issue 3, 2002, Pages 290-296

  De Muro, Pierina ^a   Fresu, Pietro ^a   Formato, Marilena ^a   Tonolo, Giancarlo ^a   Mameli, Marco ^a   Maioli, Mario ^a   Sanna, Giovanni Maria ^a   Cherchi, Gian Mario ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Glomerular basement membrane; Low sulphated chondroitin sulphate proteoglycan; Microalbuminuria; Type 1 (insulin dependent) diabetes mellitus; Urinary glycosaminoglycans

Indexed keywords

ALBUMIN; ALCIAN BLUE; CHOLESTEROL; CHONDROITIN SULFATE; CREATININE; GLYCOSAMINOGLYCAN; HEMOGLOBIN A1C; HEPARAN SULFATE; HEXURONIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; TRIACYLGLYCEROL;

ADULT; ANALYTIC METHOD; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DENSITOMETRY; DIABETES CONTROL; DIABETIC NEPHROPATHY; DISEASE DURATION; DISEASE MARKER; DIURESIS; ELECTROPHORESIS; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; ION EXCHANGE CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; METABOLIC DISORDER; METABOLIC REGULATION; MICROALBUMINURIA; PROTEIN ANALYSIS; PROTEIN ISOLATION; PROTEIN URINE LEVEL; STAIN; URINALYSIS; ALBUMINURIA; BASEMENT MEMBRANE; FOLLOW UP; HOSPITALIZATION; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; RISK FACTOR; TIME; URINE;

ADULT; ALBUMINURIA; BASEMENT MEMBRANE; CREATININE; DIABETES MELLITUS, INSULIN-DEPENDENT; DIABETIC NEPHROPATHIES; FEMALE; FOLLOW-UP STUDIES; GLYCOSAMINOGLYCANS; HUMAN; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PREDICTIVE VALUE OF TESTS; PROTEOGLYCANS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; DIABETES MELLITUS, TYPE 1; HUMANS;

EID: 0035985373     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus
2. Predicting diabetic nephropathy in insulin-dependent patients
3. Abnormal physiological process in the kidney
4. Microalbuminuria. Implications for micro- and macrovascular disease
5. Role of glycosaminoglycans in diabetic nephropathy
6. Is microalbuminuria in diabetes due to changes in glomerular heparan sulphate?
7. 1C and urinary excretion of acid glycosaminoglycans in children with diabetes mellitus
8. Urinary glycosaminoglycans, sialic acid and lysosomal enzymes increase in non albuminuric diabetic patients
9. Urinary sulphated glycosaminoglycans and Tamm-Horsfall protein in type 1 diabetic patients
10. Urinary glycosaminoglycans in patients with systemic lupus erythematosus
11. Characterization of glycosaminoglycans in urine from patients with nephrotic syndrome and control subjects, and their effects on lipoprotein lipase
12. Modified uronic acid carbazole reaction
13. A new electrophoretic method for the complete separation of all non-animal glycosaminoglycans in a monodimensional run
14. Modifications of low density lipoprotein induced by the interaction with human plasma glycosaminoglycan-protein complexes
15. Cigarette smoking is a risk factor for nephropathy and its progression in Type 2 diabetes mellitus
16. 35 S-glycosaminoglycans and 35 S-glycopeptide metabolism by diabetic glomeruli and aorta
17. Urinary excretion of glycosaminoglycans in patients with early diabetic nephropathy
18. Urinary glycosaminoglycans excretion and microalbuminuria in diabetes
19. Lack of relationship between urinary glycosaminoglycans and indices of tubular or glomerular renal damage. Urinary GAG are an unreliable nephrotoxicity index
20. Glycosaminoglycan excretion in diabetes mellitus: Relation with atherosclerosis and glomerulosclerosis
21. Decreased excretion of glycosaminoglycans in patients with primary glomerular diseases
22. Urinary excretion of acid glycosaminoglycans and its relationship to proteinuria
23. Urinary excretion of acidic glycosaminoglycans in the aged
24. Study on proteoglycans having low-sulfate chondroitin 4-sulfate in human urine and serum
25. Plasma clearance of rat bikunin: Evidence for receptor-mediated uptake
26. 125I-bovine serum albumin
27. Glycosaminoglycan therapy for long-term diabetic complications?
28. Glomerular basement membrane anionic charge site changes early in aminonucleoside nephrosis
29. Heparan sulfate-rich anionic sites in the human glomerular basement membrane. Decreased concentration in congenital nephrotic syndrome
30. Heparan sulfate proteoglycan in the glomerular basement membrane in type 1 diabetes mellitus
31. Glomerular and urinary heparan sulphate in congenital nephrotic syndrome
32. Urine glycosaminoglycans and heparan sulfate excretions in adult patients with glomerular diseases
33. Distribution of GBM heparan sulfate proteoglycan core protein and side chains in human glomerular diseases
34. Urinary glycosaminoglycan excretion in NIDDM subjects: Its relationship to albuminura